Hemophilia Gene Therapy Now Backed By European Regulators
The agency that suggests which medications should be allowed in Europe has backed five new ones, including a gene therapy for haemophilia, a combo...
WHO Revises Treatment Recommendations For Drug-Resistant TB
The World Health Organization (WHO) has released its revised consolidated recommendations for treating drug-resistant tuberculosis (DR-TB), which include significant advancements in the treatment options...
By 2032, The Alzheimers Treatments Market Will Be $6.8 Bn
The global Alzheimer's therapeutics market is anticipated to develop at a compound annual growth rate (CAGR) of 9.3% and reach $6.8 billion by 2032, according...
The Pharmaceutical Market In 2023- Trends And Predictions
The pharmaceutical sector has grown quickly in recent years, and by 2023 it is anticipated to reach USD 1.5 trillion. With the use of...
Quality Assurance Advances In Pharmaceutical Manufacturing
The needs of manufacturing facilities, tools, and procedures must be suitable for this new environment as the focus of new drug research shifts toward...
6 Issues In Pharma-Biotech Patent Disputes To Watch In 2023
Who will file a lawsuit under the UPC first?
The deadline for opting out of patents will begin on March 1, 2023, and the UPC...
New Zealand Health Agencies Aim To Improve Clinical Trials
Based on recommendations from an independent study report titled Enhancing Aotearoa New Zealand Clinical Trials, New Zealand's top health agencies will examine system-level adjustments...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...